tiprankstipranks
Oncternal Therapeutics announces updated data from Phase 1/2 study of ONCT-534
PremiumThe FlyOncternal Therapeutics announces updated data from Phase 1/2 study of ONCT-534
1M ago
Oncternal Therapeutics Restructures Amid Clinical Setbacks
Premium
Company Announcements
Oncternal Therapeutics Restructures Amid Clinical Setbacks
2M ago
Oncternal Therapeutics downgraded to Market Perform from Outperform at Northland
Premium
The Fly
Oncternal Therapeutics downgraded to Market Perform from Outperform at Northland
2M ago
Oncternal Therapeutics price target lowered to $18 from $19 at H.C. Wainwright
PremiumThe FlyOncternal Therapeutics price target lowered to $18 from $19 at H.C. Wainwright
4M ago
Oncternal Therapeutics reports Q2 EPS ($2.89 ), consensus ($3.10)
Premium
The Fly
Oncternal Therapeutics reports Q2 EPS ($2.89 ), consensus ($3.10)
4M ago
ONCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ONCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Oncternal Therapeutics reports Q1 EPS ($2.83), consensus ($2.88)
PremiumThe FlyOncternal Therapeutics reports Q1 EPS ($2.83), consensus ($2.88)
7M ago
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
Premium
The Fly
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
7M ago
ONCT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ONCT Earnings this Week: How Will it Perform?
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100